Atlas Trials

Feasibility of a New Diagnostic Device to Assess Small Intestinal Dysbiosis in Routine Clinical Setting.

Clinical trial NCT04910815 · UNKNOWN

Trial details

NCT number
NCT04910815
Sponsor
Atmo Biosciences Pty Ltd
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Small Intestinal Bacterial Overgrowth
Start date
2021-07-14
Primary completion
2024-06-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.